Patient
P2B-056
completed Phase IIA Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Oncological Institute "Prof. Dr. I. Chiricuta", Cluj-Napoca (Cluj-Napoca, Romania) (Dr. Novak)
consented 2012-12-02
Adverse events
3
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 3
Grade 1 fatigue with onset in cycle 1 (2012-12-27); assessed as not related to study drug (unlikely); not resolved at last follow-up.
Grade 3 decreased appetite with onset in cycle 1 (2012-12-25); assessed as not related to study drug (not related); not resolved at last follow-up; action: drug interrupted.
Grade 1 constipation with onset in cycle 1 (2012-12-16); assessed as related to study drug (possible); resolved 2012-12-19.
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.